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A physically active life-style plays an independent role in the protection against type 2 dia-
betes and cardiovascular diseases. Irisin, a novel exercise-induced myokine, activates ther-
mogenesis in rodents through increasing beige fat cells abundance within white fat. We
aimed to investigate circulating irisin levels in association with the degree of physical activity
and various metabolic parameters in humans.
Methods
Circulating irisin levels (ELISA) and metabolic parameters were analyzed in 428 subjects
(195 men/233 women). Participants were classified according to their self-reported physical
activity and to their area of residence.
Results
Circulating irisin levels were higher in active than in sedentary subjects (p= 0.006). Rural
inhabitants showed higher circulating irisin levels than urban subjects (p < 0.0001). The
increase in irisin levels related to an active lifestyle was only observed in rural citizens
(p = 0.014). Among sedentary participants, irisin levels were positively associated with
metabolic risk factors (BMI, fasting insulin, HOMA and fasting triglycerides). The area of res-
idence (β= - 0.592, p= < 0.0001) contributed independently to circulating irisin levels vari-
ance after controlling for age, gender, BMI, HOMAIR, triglycerides and physical activity.
Conclusions
In sedentary participants, circulating irisin levels were positively associated with parameters
related to an increased cardiometabolic risk. The present study confirmed that an active
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lifestyle increases circulating irisin levels, but only among subjects living in a rural environ-
ment. Area of residence might be a determinant of irisin levels.
Introduction
There is accumulating epidemiological evidence that a physically active life-style plays an inde-
pendent role in the protection against type 2 diabetes, cardiovascular diseases, cancer, dementia
and even depression. Current trends confirm that physical activity induces an increase in the
systemic levels of a number of cytokines which contribute to tissue communication that is es-
sential to maintain metabolic homeostasis [1]. In this context, the muscle tissue has recently
been recognized as an endocrine organ that releases a variety of cytokines, termed myokines,
which regulate several physiological and metabolic pathways. Since the discovery of interleukin
(IL)-6 as a muscle-secreted cytokine, a number of myokines have been identified, including
myostatin, leukemia inhibitory factor (LIF), IL-8 and IL-15 [2, 3].
In 2012, irisin, a new myokine was identified. It is a proteolytic cleavage product of FNDC5
which expression is induced by PPARγ coactivator 1 alpha (PGC1-α). This gene expression is
induced by exercise which in turns stimulate irisin releasing into the circulation. This process
increase energy expenditure and thermogenesis by increasing uncoupling protein 1 (UCP1)
levels via increased PPAR-α expression in white adipose tissue. Irisin is highly conserved
among species, with mouse and human being 100% identical, supporting the notion for having
a highly conserved function in mammals [4].
Previous reports have shown either mice or human have higher irisin plasma levels after ex-
ercise [4, 5]. However, conflicting data on the role of exercise in irisin levels have emerged,
since this issue has not been confirmed in a radomized controlled trial performed in 102 un-
trained participants during 6 months [6] or in an exercise intervention conducted in 16 seden-
tary overweight/obese subjects during 3 months [7], among others. Indeed, Timmons et al.,
using gene expression arrays, detected an exercise-induced increase of FNDC5 mRNA in
human muscle biopsies from old but not from young subjects [8]. The threshold of exercise re-
quired to produce these effects might be crucial, because acute exercise has been demonstrated
to result in increased serum irisin concentrations in humans [5, 9]. Recently, Lee et al. have re-
ported that exercise-induced irisin secretion may have evolved from shivering related muscle
contraction [10].
Irisin has been proposed to be produced by adipocytes [11, 12], although in lower quantities.
Concerning metabolic factors, discrepant results have been obtained in the association between
irisin and BMI. While, recent reports have proved that circulating irisin levels were positively
correlated with BMI, fasting glucose and total cholesterol [5, 13, 14] other studies found an in-
verse association with these parameters [12, 15]. In addition, distinct patterns of Fndc5 or irisin
have been found in muscle, adipose tissue or in circulation [7]. Metabolic factors such glucose
or fatty acids could have a role in irisin regulation [7]. Despite the lack of uniformity, these con-
flicting results suggested that, body composition, gender, and age may modulate effects of
physical exercise on irisin levels.
The stimulation of beige/bride adipocytes in human adipose tissue has been postulated as a
possible therapeutic way to improve obesity-associated metabolic disturbances [16]. Since iri-
sin is a circulating factor that activates beige fat cells in rodents [17], it could represent one way
to perform this action in humans. The purpose of our study was to investigate the association
between an active lifestyle and the circulating irisin levels in a mixed rural—urban Spanish
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population. To gain insights on the role of irisin in humans, we also examined its associations
with various metabolic parameters.
Methods
Study population
The Ethical Committee from Investigación del Principado de Asturias affirms that the research
Project entitled: "Prevalence of Diabetes Mellitus type II in The Asturian population of 30 years
of age or more" has been evaluated and approved by this Committee in October 1997 under
number #87/1997. Participants provide their written informed consent to participate in this
study. The Asturias Study is a prospective population-based survey of diabetes and cardiovas-
cular risk factors. The baseline examination was carried out during 1998–1999 in the Principal-
ity of Asturias in northern Spain. As described in detail previously [18], the population of
Asturias is 1 073 761 and mostly Caucasian. Approximately half of the population lives in
urban areas. A two-step sampling technique was used. Fifteen basic health areas were selected
at random from among the 76 in Asturias with a probability proportional to the number of
health cards of users aged between 30 and 75 years. A computer program was then used to ran-
domly select 125 individuals in each basic health area. The final sample size selected was 1 875;
87 individuals were excluded for various reasons (type 1 diabetes, pregnancy, severe disease,
hospitalization, or use of diabetogenic drugs). Another 162 individuals were excluded because
data needed to contact them were missing. The final sample was composed of 1 626 individu-
als, of whom 1 034 (63.6%) responded. Vital status and current residency of all individuals
were obtained from their health service identification card. Of the original cohort, 42 individu-
als had died and 19 had left Asturias before the follow-up started. Thirty other individuals were
excluded (because of pregnancy, severe disease, hospitalization, or use of diabetogenic drugs).
Of the remaining 943 individuals, 700 participated (74.2%). The present study includes only
those individuals who did not have diabetes at the baseline.
Clinical examination
All examinations and analyses were performed at the patients’ local health centers by an endo-
crinologist and a trained nurse. Information on demographic data and physical activity was ob-
tained by questionnaire used in previous published studies [18]. The participants were asked
about the intensity of their leisure time physical activity and whether they practiced any sport.
There were three categories: “low,” almost completely inactive; “moderate,” some physical ac-
tivity 1 h/day, e.g., walking, gardening, dancing, or bicycling; or “high,” vigorous physical activ-
ity 3 h/week, e.g., running, swimming, ball games, or competitive sports. The area of residence
was classified according to the municipal population: “rural,”< 10 000 inhabitants; “medium,”
10 000–50 000 inhabitants; or “urban,”> 50 000 inhabitants, as described in detail previously
[18]. Medical records were reviewed to investigate previous diseases or medication. Height,
weight, and BMI (weight in kilograms divided by the square of height in meters) were mea-
sured with the subject wearing light clothing and without shoes. Percent fat mass was calculat-
ed using the Deurenberg equation [%Fat = 1.20 x BMI + 0.23 x age - 10.8 (if male)- 5.4] [19]. A
dichotomous physical activity variable was created based on whether or not the participant
met national physical activity guidelines (150 minutes/week on 5 days/week of moderate
intensity activity or 60 minutes/week on 3 days/week of vigorous intensity activity). Those
who met guidelines were classified as active and those who did not were classified as insuffi-
ciently active/inactive/sedentary.
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Analytical Methods
The samples were centrifuged in situ using a portable centrifuge. A portable refrigerator con-
taining the samples was taken daily to the Biochemical Laboratory of the Central Hospital of
Asturias. Glucose was determined by the hexokinase enzymatic method (Hitachi 747), as de-
scribed in detail previously [18].
Additional laboratory measurements included total cholesterol, HDL cholesterol, triglycerides
(colorimetric method), LDL cholesterol (Friedewald formula), and HbA1c (high-performance
liquid chromatography, Adams HA-8160). Serum insulin was measured in duplicate in the same
centralized laboratory by a monoclonal immunoradiometric assay (Medgenix Diagnostics,
Fleunes, Belgium). The intra-assay CV was 5.2% at a concentration of 10 mU/l and 3.4% at 130
mU/l. The inter-assay CVs were 6.9 and 4.5% at 14 and 89 mU/l, respectively, as described in de-
tail previously [20]. Insulin resistance was determined by the homeostasis model assessment of
insulin resistance (HOMAIR)
Plasma irisin concentrations were measured within the same day using ELISA (SK00170-
01, AVISCERA BIOSCIENCE INC, Santa Clara, California, USA). Intra- and inter-assay
coefficients of variation for these determinations were between 4–6% and between 8–10%,
respectively.
Statistics
Statistical analyses were performed using SPSS 19.0 software for Windows (IBM Corp.,
Armonk, NY, USA). All assays were performed at least in duplicate and reported as
mean ± SD. The comparison between groups was performed using two-way ANOVA followed
by post-hoc analysis (using DMS and Bonferroni post hoc tests). The relation between vari-
ables was analyzed by bivariate correlation (Pearson’s or Spearman’s test) and multiple linear
regression models (using stepwise method). Because irisin levels are influenced by the area of
residence, the association between irisin and metabolic parameters was calculated by using par-
tial correlation coefficients. Categorical data were expressed as proportion and compared by χ2
test. p< 0.05 was considered as statistically significant.
Results
Characteristics of the study participants
The clinical and biochemical characteristics of the study subjects are presented in table 1. The
range in age was 30.2 to 76.9 years old (median age was 52 years). The range in BMI was 20.6
to 47.8 kg/m2. Subjects had a mean plasma irisin concentration of 112.23 ± 66.46 ng/ml, rang-
ing from 31.34 to 336.84 ng/ml.
No significant differences in circulating irisin according to gender were found (114.9 ± 67.9
ng/ml in men vs 108.9 ± 64.6 ng/ml in women, p = 0.3).
Circulating irisin levels and physical activity
A dichotomous physical activity variable was created based on whether (= active subjects) or
not (= sedentary subjects) the participants practice any physical activity. Interestingly, circulat-
ing irisin levels were significantly higher in active than in sedentary subjects (128.55 ± 78.71 vs
105.66 ± 60.2, p = 0.006) (Fig 1).
Moreover, in order to study the exercise impact on circulating irisin levels in more depth,
we have classified subjects into three categories (low, moderate and high), according to their
self-reported physical activity. In this regard, no differences were found in circulating irisin lev-
els between participants who displayed low or moderate physical activity (p>0.05). However,
Irisin and Physical Activity
PLOS ONE | DOI:10.1371/journal.pone.0124100 April 21, 2015 4 / 11
subjects with a high physical activity showed higher levels of circulating irisin (128.5 ± 78.7 ng/
mL) than participants with a moderate (107.3 ± 64.6 ng/mL, p = 0.021) or low physical activity
(102.9 ± 52.8 ng/mL, p = 0.010), respectively.
Interestingly, by dividing subjects according to their area of residence, rural inhabitants show
significantly higher circulating irisin levels than medium or urban subjects (p =< 0.0001). Spe-
cifically, in rural inhabitants circulating irisin levels were 183.81 ± 68.8 ng/mL and decreased
significatively to 84.03 ± 32.97 and 82.11 ± 38.0 ng/mL in medium and urban subjects, respec-
tively (Fig 2). According to physical activity, we have evaluated the circulating irisin levels in
these three different settings, we have found that irisin levels were higher in active than in seden-
tary subjects only in rural inhabitants (p = 0.014) while no differences were shown in citizens
living in urban or medium environments (Fig 3).
Correlation of circulating irisin with metabolic parameters
In the total study group irisin levels were positively associated to weight (r = 0.129, p = 0.008),
BMI (r = 0.148, p = 0.002), HDL (r = -0.194, p = 0.001), triglycerides (r = 0.172, p =<0.0001),
insulin (r = 0.113, p = 0.020) and HOMAIR (r = 0.101, p = 0.037). Interestingly, obese subjects
(BMI> 30 kg/m2) showed higher irisin levels than non-obese participants (BMI< 30 kg/m2)
(106.93 ± 63.5 vs 124.66 ± 71.5, p = 0.016). Correlation coefficients between irisin levels with
the measured clinical parameters according to self-reported leisure time physical activity are
presented in Table 2. Among sedentary participants, circulating irisin levels were negatively
Table 1. Anthropometric and clinical parameters of study subjects according to their area of residence.
Rural Medium Urban
N 123 109 189
Gender (men/women) 57/66 49/60 85/104
Age (years) 53.02 ± 13.37 53.18 ± 12.96 53.55 ± 11.89
SBP (mmHg) 136.60 ± 22.3 135.86 ± 22.33 137.88 ± 21.96
DBP (mmHg) 79.32 ± 10.13 78.01 ± 9.42 79.43 ± 9.01
Weight (kg) 76.79 ± 14.83 74.30 ± 13.63 73.21 ± 12.85
BMI (kg/m2) 29.29 ± 4.52 # 28.37 ± 4.15 27.57 ± 4.23
Percent fat mass (%) 38.4 ± 1 7.6 37.2 ± 8.4 36.2 ± 7.9
Waist circumference (cm) 95.10 ± 13.01 93.13 ± 12.25 92.03 ± 12.68
Hip circumference (cm) 106.49 ± 9.24 105.25 ± 8.5 105.18 ± 8.08
Waist-to-hip ratio 0.89 ± 0.08 0.88 ± 0.07 0.87 ± 0.08
Fasting glucose (mmol/L) 5.50 ± 1.84 5.49 ± 1.18 5.50 ± 1.35
Fasting insulin (pmol/L) 55.08 ± 30.0 51.66 ± 38.09 55.08 ± 31.74
HOMAIR 2.32 ± 1.65 2.20 ± 1.92 2.31 ± 1.58
HbA1c (mmol/mol) 30 ± 8.6 30 ± 6.4 29 ± 6.9
Total cholesterol (mmol/L) 5.49 ± 0.94 5.42 ± 0.99 5.56 ± 0.87
HDL-cholesterol (mmol/L) 1.41 ± 0.35 # 1.48 ± 0.36 1.55 ± 0.41
LDL-cholesterol (mmol/L) 3.45 ± 0.9 3.35 ± 0.87 3.44 ± 0.80
Triglycerides (mmol/L) 1.34 ± 0.72 1.27 ± 0.73 1.24 ± 0.65
Adiponectin (μg/mL) 15.82 ± 8.4 15.73 ± 7.3 14.55 ± 9.7
Irisin (ng/mL) 183.8 ± 68.83 *# 84.03 ± 32.97 82.11 ± 38.02
Physical activity (Yes %) 33.6 * 21.2 23.8
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; HOMA, homeostasis model assessment.; HDL, high
density lipoprotein; LDL, low density lipoprotein. Mean ± s.d. Statistically signiﬁcant values are indicated in bold (* = rural Vs medium; # = rural Vs urban).
doi:10.1371/journal.pone.0124100.t001
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associated with HDL-cholesterol and positively with BMI, fasting insulin, HOMAIR and total
serum triglycerides. Moreover, no significant correlations with age, fasting glucose, HbA1c or
adiponectin were found. Surprisingly, in active subjects, a Spearman’s correlation test showed
that no parameter was positively associated with circulating irisin levels. However, an inverse
association between irisin levels and HDL-cholesterol was observed.
In multiple linear regression models, the area of residence (β = - 0.592, p =< 0.0001) con-
tributed independently to circulating irisin levels variance after controlling for age, gender,
BMI, HOMAIR, triglycerides and physical activity. We also employed general linear model to
further address the potential confounding of area of residence in comparison of irisin levels
and metabolic parameters. The model revealed that the association between circulating irisin
levels and insulin and HOMAIR remained statistically significant after adjustment for the area
of residence (p< 0.05).
Discussion
Similar to the adipose tissue, muscle was also suggested to be an “endocrine organ” with myo-
kines providing cross-talk between adipose tissue, the immune system, hypothalamus and
muscle cells [13]. Boström et al. report that exercise training induces FNDC5 gene expression
in human muscle, producing irisin, which can convert white fat into brown fat, so enhancing
metabolic uncoupling and hence caloric expenditure [4]. In this cross-sectional study, we re-
port the circulating irisin levels in a representative sample of the general population of a whole
province in northern Spain, including residents in both urban and rural areas.
Fig 1. Circulating irisin levels according to self-reported leisure time physical activity in the study
participants (n = 428).
doi:10.1371/journal.pone.0124100.g001
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A few reports in rodents and humans have shown that exercise increases circulating irisin
levels [4, 5] while others have been unable to reproduce the increase in circulating irisin levels
after training interventions [6, 7]. Since acute exercise results in increased circulating irisin lev-
els [5, 9], it seems that a threshold of exercise intensity and/or duration is required to produce
these effects. Taking all participants as a whole, our analysis derived from adult subjects who
regularly practice physical activity reflects that a high level of physical activity is associated
with increased circulating irisin levels, at least in a rural environment. Importantly, this was
not observed in participants from medium and urban area.
The current study is the first examination of rural-urban differences in circulating irisin lev-
els. We have shown that rural inhabitants display higher circulating irisin levels than urban cit-
izens, both in men and women. For this reason, the influence of rural/urban location prompted
us to explore the irisin levels according to the physical activity in each area. Our results show
that the increase in circulating irisin levels related to an active lifestyle was only observed in
rural citizens and no differences were found in urban or medium inhabitants. However, it has
been reported, in diverging populations, the increased cardiometabolic risk in urban popula-
tions, suggesting that a good health profile appears significantly more widespread among those
living in rural areas [21, 22]. Therefore, besides the augmented cardiovascular risk factors in
urban areas, we cannot rule out environmental differences such as food habits or pollution lev-
els between rural and urban settings that might be influencing circulating irisin concentrations.
In this regard, persistent organic pollutants have been reported to impair the adipokine axis
or fat metabolism, resulting in inappropiated low adiponectin levels [23, 24]. Apart from the
Fig 2. Circulating irisin levels according to the area of residence (n = 428) (only significant differences are shown).
doi:10.1371/journal.pone.0124100.g002
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theoretical effect of exercise on irisin regulation, other metabolic factors such as glucose or
fatty acids have been proposed as important modulators impacting on circulating irisin levels
[7]. In this setting, muscle mass was a strong positive predictor of irisin levels, supporting the
view that irisin is mainly secreted by the muscle [5, 13]. Anastasilakis et al. have also reported a
day-night rhythm of secretion for irisin [9]. Despite the accumulated evidence, the real irisin
regulators have not been fully elucidated so far.
By analyzing the association between circulating irisin levels and anthropometric parameters,
we have shown a negative association between circulating irisin levels and HDL-cholesterol in
both sedentary and active subjects, as recently observed [25]. Moreover, among sedentary sub-
jects, our data reflects that circulating irisin levels were positively associated with parameters re-
lated to an increased cardiometabolic risk such as: BMI, fasting insulin, HOMAIR and fasting
triglycerides. Previous studies have reported that irisin levels are decreased in patients with type
2 diabetes, while positively correlated with BMI across a broad spectrum of body weights how-
ever they have not taken into account the physical activity factor [5, 13, 14]. Because irisin is a
myokine that is induced by exercise, it is difficult to evaluate the association between irisin level
and clinical parameters without exercise information. In agreement with previous reports
[5,16], we hypothesize that the association between irisin levels and metabolic risk factors in
sedentary subjects, raises the question of a compensatory role for this myokine to provide a
counterbalance to the increased risk of the progression of chronic disorders in an inactive life-
style. In this sense, Polyzos et al. proposed the term “irisin resistance” or irisin desensitization to
Fig 3. Circulating irisin levels according to the area of residence based on their self-reported leisure
time physical activity categories (n = 428) (only significant differences are shown).
doi:10.1371/journal.pone.0124100.g003
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explain the apparently discordant upregulation of irisin with obesity and glucose intolerance
[26]. Indeed, Kurdiova et al. have suggested that irisin might distinguish different metabolic
profiles since distinct patterns of Fndc5 or irisin have been found in muscle, adipose tissue or
circulation [7].
With the current study, the circulating irisin level profile has been depicted in a Spanish
northern population. We have shown that an active lifestyle increases circulating irisin levels
and that irisin is positively associated with several parameters related to an increased cardiome-
tabolic risk, in sedentary subjects. Moreover, we propose that additional factor such as the area
of residence might be determinant in the irisin levels. The causality of the observed associations
between study parameters should be more intensively studied in prospective cohort and inter-
ventional studies. These findings suggest that differences in baseline exercise characteristics be-
tween groups should be considered when interpreting results of irisin studies.
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Table 2. Bivariate correlation among circulating irisin levels and anthropometric and clinical parameters according to self-reported leisure time
physical activity.
Physical activity
Sedentary (n = 317) Active (n = 110)
r p-value r p-value
Age (years) 0.001 0.993 - 0.095 0.325
Weight (kg) 0.114 0.043 0.158 0.099
BMI (kg/m2) 0.151 0.007 0.170 0.075
Percent fat mass (%) 0.108 0.054 -0.011 0.908
SBP (mmHg) - 0.036 0.519 - 0.008 0.933
DBP (mmHg) 0.007 0.896 - 0.011 0.908
Waist-to-hip ratio 0.072 0.204 0.149 0.125
Fasting glucose (mg/dL) 0.050 0.375 0.010 0.920
HbA1c (mmol/mol) 0.071 0.207 - 0.029 0.766
Fasting insulin (mU/L) 0.150 0.008 0.056 0.563
HOMAIR 0.143 0.011 0.037 0.698
Fasting cholesterol (mg/dL) - 0.014 0.799 - 0.006 0.947
HDL-cholesterol (mg/dL) - 0.130 0.021 - 0.188 0.049
LDL-cholesterol (mg/dL) - 0.020 0.723 0.038 0.698
Fasting triglycerides (mg/dL) 0.194 0.001 0.117 0.222
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; HOMA, homeostasis model assessment.; HDL, high
density lipoprotein; LDL, low density lipoprotein. Statistically signiﬁcant values are indicated in bold.
doi:10.1371/journal.pone.0124100.t002
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